Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising progress across different healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, extra reputable choice for therapeutic use, especially in d